List of Narcan drug patents

Narcan is owned by Emergent.

Narcan contains Naloxone Hydrochloride.

Narcan has a total of 8 drug patents out of which 0 drug patents have expired.

Narcan was authorised for market use on 18 November, 2015.

Narcan is available in spray, metered;nasal dosage forms.

Narcan can be used as use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression..

The generics of Narcan are possible to be released after 16 March, 2035.

NARCAN Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9629965 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US10085937 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9480644 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9775838 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9561177 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9707226 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9468747 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

US9211253 EMERGENT Nasal drug products and methods of their use
Mar, 2035

(11 years from now)

Do you want to check out NARCAN patents from before 2022?

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 18 November, 2015

Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dosage: SPRAY, METERED;NASAL

How can I launch a generic of NARCAN before it's patent expiration?
More Information on Dosage

NARCAN family patents

23

United States

3

Japan

3

European Union

2

Russia

2

China

2

Israel

2

Canada

2

Singapore

2

Mexico

1

Germany

IB

1

IB

1

Hong Kong

1

Spain

1

Australia

1

United Kingdom

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in